Health and Human Services News and Research

RSS

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

$Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients$

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times when compared to conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates, when compared to observation alone following surgical resection of brain metastases, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Researchers identify, validate three distinct molecular subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

A new analysis of records in the Veteran's Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in recent years, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

FDA approves new biosimilar for multiple inflammatory diseases

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.

23 Sep 2016

UofL researchers receive NIH funding to explore how environmental exposures influence health of children

The National Institutes of Health today announced a team of researchers headed by Janice Sullivan, M.D., of the University of Louisville is among grant recipients nationwide receiving funding for a seven-year, multicenter initiative called Environmental influences on Child Health Outcomes.

21 Sep 2016

Sanford wins $11.7 million NIH grant to translate laboratory cancer research into clinical trials

The Cancer Biology Research Center at Sanford Research is the recipient of a five-year, nearly $11.7 million grant from the National Institutes of Health to translate laboratory research into clinical trials for head and neck and pediatric cancers.

20 Sep 2016

Sarepta Therapeutics wins accelerated approval from FDA for Duchenne muscular dystrophy drug

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD).

19 Sep 2016

FDA authorizes marketing of new Aera system to treat patients with chronic ETD symptoms

The U.S. Food and Drug Administration today permitted marketing of a device that uses a small balloon to treat persistent Eustachian tube dysfunction (ETD), a condition in which pressure, pain or clogged or muffled sensations occur in the ear.

16 Sep 2016

FDA warns retailers for selling newly regulated tobacco products to minors

The U.S. Food and Drug Administration announced today it has taken action against 55 tobacco retailers by issuing the first warning letters for selling newly regulated tobacco products, such as e-cigarettes, e-liquids and cigars, to minors.

15 Sep 2016

Incorporating laughter into exercise program could provide health benefits to older adults

Incorporating laughter into a physical activity program that is focused on strength, balance and flexibility could improve older adults' mental health, aerobic endurance and confidence in their ability to exercise, according to a study led by Georgia State University.

15 Sep 2016

FDA approval of VisuMax Femtosecond Laser expands surgical treatment options for myopia

The U.S. Food and Drug Administration today approved the VisuMax Femtosecond Laser for the small incision lenticule extraction (SMILE) procedure to reduce or eliminate nearsightedness in certain patients 22 years of age or older.

14 Sep 2016

FDA awards $21.8 million to support states in implementing FSMA produce safety rule

The U.S. Food and Drug Administration today announced the awarding of a total of $21.8 million to support 42 states to help implement the FDA Food Safety Modernization Act (FSMA) produce safety rule.

9 Sep 2016

TB lesions may remain in lungs long after completion of treatment

Patients with active tuberculosis of the lungs, the infectious form of the disease known as pulmonary tuberculosis (TB), are typically treated with several medications for a period of six months.

7 Sep 2016

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina.

2 Sep 2016

Complementary health approaches appear to be effective in helping manage pain

Data from a review of U.S.-based clinical trials published today in Mayo Clinic Proceedings suggest that some of the most popular complementary health approaches--such as yoga, tai chi, and acupuncture--appear to be effective tools for helping to manage common pain conditions.

1 Sep 2016

Hospitalizations for injection drug use-related infective endocarditis increasing among young Americans

Hospitalizations for infective endocarditis, a heart valve infection often attributed to injection drug use, have increased significantly among young adult Americans--particularly in whites and females--according to a new study by researchers from Tufts Medical Center and Tufts University School of Medicine.

1 Sep 2016

Surveys find public awareness about heart valve disease alarmingly low in the U.S.

New public opinion surveys released today by the nonprofit Alliance for Aging Research show that public awareness about heart valve disease (HVD) in the U.S. is alarmingly low.

31 Aug 2016

FAU's College of Nursing receives HRSA grant for advanced education program

The Christine E. Lynn College of Nursing at Florida Atlantic University has received a three-year, $2 million grant from the Health Resources & Services Administration of the U.S. Department of Health and Human Services for an advanced nursing education program titled, "Caring-based Academic Partnerships to Enhance Nurse Practitioner Readiness and Willingness to Practice in Rural and Underserved Communities."

31 Aug 2016

Health and Human Services News and Research

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

FDA approves new biosimilar for multiple inflammatory diseases

UofL researchers receive NIH funding to explore how environmental exposures influence health of children

Sanford wins $11.7 million NIH grant to translate laboratory cancer research into clinical trials

Sarepta Therapeutics wins accelerated approval from FDA for Duchenne muscular dystrophy drug

FDA authorizes marketing of new Aera system to treat patients with chronic ETD symptoms

FDA warns retailers for selling newly regulated tobacco products to minors

Incorporating laughter into exercise program could provide health benefits to older adults

FDA approval of VisuMax Femtosecond Laser expands surgical treatment options for myopia

FDA awards $21.8 million to support states in implementing FSMA produce safety rule

TB lesions may remain in lungs long after completion of treatment

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Complementary health approaches appear to be effective in helping manage pain

Hospitalizations for injection drug use-related infective endocarditis increasing among young Americans

Surveys find public awareness about heart valve disease alarmingly low in the U.S.

FAU's College of Nursing receives HRSA grant for advanced education program

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News